KS
Highly rated in
3
conditions
Highly rated in
3
conditions

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

About Dr. Kazuya Sumi

Kazuya Sumi is in Toyosu, Japan. Dr. Sumi is highly rated in 3 conditions, according to our data. His top areas of expertise are Gastroesophageal Reflux Disease, Achalasia, Esophageal Cancer, and Toxic Megacolon.

His clinical research consists of co-authoring 36 peer reviewed articles in the past 15 years.

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Locations
  Toyosu, JP
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
University Of Tokyo
 
Tokyo, JP 
 10.0 km
Masaomi Nangaku is in Tokyo, Japan. They have been an author on 445 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
Keio University School Of Medicine
 
Tokyo, JP 16085
 10.0 km
Tsutomu Takeuchi is in Tokyo, Japan. They have been an author on 504 peer reviewed articles and participated in 6 clinical trials in the past 15 years.
Highly rated in
0
conditions
Nippon Medical School Graduate School Of Medicine
 
Tokyo, JP 
 10.0 km
Masataka Kuwana is in Tokyo, Japan. They have been an author on 293 peer reviewed articles and participated in 2 clinical trials in the past 15 years.